Stay updated on Pembrolizumab & Enfortumab in Rare Kidney Cancers Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab & Enfortumab in Rare Kidney Cancers Clinical Trial page.

Latest updates to the Pembrolizumab & Enfortumab in Rare Kidney Cancers Clinical Trial page
- Check4 days agoChange DetectedThe homepage statistic for total studies updated from 595,630 to 596,690, reflecting a larger registry of trials across the United States and internationally.SummaryDifference0.1%

- Check11 days agoChange DetectedThe homepage’s total study count updated from 594,543 to 595,630, and the site revision tag updated from v3.6.3 to v3.6.4. This reflects a new release and the current scope of studies displayed.SummaryDifference0.3%

- Check18 days agoChange DetectedThe homepage now displays the updated total number of studies (594,543) instead of the previous figure (593,334). This reflects current data on registered studies and provides users with a refreshed sense of the database size.SummaryDifference0.1%

- Check26 days agoChange DetectedThe homepage now states ClinicalTrials.gov hosts 593,334 studies across all 50 states and 226 countries and territories, updating the stated total to reflect current scope.SummaryDifference0.1%

- Check33 days agoChange DetectedThe homepage now shows 592,210 studies with locations in all 50 states and 226 countries and territories, and it displays Revision: v3.6.3, updating the database size and version on the site.SummaryDifference0.3%

- Check40 days agoChange DetectedThe homepage now reports 591,437 studies across all 50 states and 226 countries, replacing the previous figure of 590,354. The site revision line updates from v3.6.0 to v3.6.2.SummaryDifference0.3%

Stay in the know with updates to Pembrolizumab & Enfortumab in Rare Kidney Cancers Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab & Enfortumab in Rare Kidney Cancers Clinical Trial page.